Chulabhorn Royal Academy all news related to

Thai FDA approves IMCRANIB 400 to widen cancer drug access

May 20, 2026

Thai FDA approves IMCRANIB 400, a locally made targeted cancer drug designed to improve access, reduce imports and simplify treatment.

Cervical cancer is preventable and treatable if detected early

March 11, 2023

Cervical Cancer is a major public health burden with significant social and economic impact on health systems, national economies, and affected women and their families.

Go for 2 vaccine doses per year: Chulabhorn Royal Academy

THURSDAY, JULY 07, 2022

People should receive two Covid-19 vaccine shots per year in the current situation, Chulabhorn Royal Academy said.

Zuellig delivers Moderna vaccine for Covid, in time for Songkran

THURSDAY, MARCH 31, 2022

Zuellig Pharma has delivered the first lot of 376,320 Moderna vaccines to Chulabhorn Royal Academy on Tuesday.

Chulabhorn academy seminar to offer public insights into digital health trends

MONDAY, MARCH 21, 2022

Chulabhorn Royal Academy (CRA) is inviting people to attend a seminar “CRA Digital Health” to offer knowledge and views on digital health trends, and launch the CRA Digital Health Programme.

All News Chulabhorn Royal Academy In Focus Chulabhorn Royal Academy BreakingNews of Chulabhorn Royal Academy Your Interested Follow Story Chulabhorn Royal Academy

Thai FDA approves IMCRANIB 400 to widen cancer drug access

Cervical cancer is preventable and treatable if detected early

Go for 2 vaccine doses per year: Chulabhorn Royal Academy

Zuellig delivers Moderna vaccine for Covid, in time for Songkran

Chulabhorn academy seminar to offer public insights into digital health trends